Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Long-Term Debt Repayments (2016)

ENDRA Life Sciences (NDRA) has disclosed Long-Term Debt Repayments for 1 consecutive years, with -$132000.0 as the latest value for Q4 2016.

  • Quarterly Long-Term Debt Repayments changed N/A to -$132000.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was -$132000.0 through Sep 2018, changed N/A year-over-year, with the annual reading at $28484.0 for FY2024, N/A changed from the prior year.
  • Long-Term Debt Repayments for Q4 2016 was -$132000.0 at ENDRA Life Sciences.
  • The five-year high for Long-Term Debt Repayments was -$132000.0 in Q4 2016, with the low at -$132000.0 in Q4 2016.